Global Ganja Report

British firm GW Pharmaceuticals has won "orphan drug status"—a special category for agents developed to treat rare diseases—from the US Food and Drug Administration (FDA) for Epidiolex, a derivative of cannabidiol (CBD), to treat Dravet syndrome, a severe form epilepsy. In Utah, parents who are lobbying to import CBD-rich cannabis strains from Colorado, say they will keep up their campaign. "This changes nothing" in regard to children being able to access CBD, said Jennifer May, mother of 11-year-old Stockton, who suffers from Dravet syndrome. "On the other hand, it does lend credibility to the potential of CBD as a treatment." Like many Dravet patients, Stockton has tried dozens of pharmaceutical fixes, and run out of options. He can no longer use the toilet and has to be fed from a tube. "Orphan drug" designation qualifies GW for tax credits and exclusive rights to the drug if approved. But FDA approval for Epidiolex could take a year or more. (Salt Lake Tribune, Nov. 18)

OK, no pun intended, but this one doesn't pass the smell test. Reuters reports all too credulously Nov. 1 that doctors in Albania say hundreds of people have fallen ill from harvesting cannabis. The hospital in the southern city of Gjirokaster said some 700 have sought treatment since June for the effects of planting, harvesting, pressing and packing the crop. "In the last two months about seven to eight people arrive in the emergency ward each day and many more have come earlier with disorders from hashish," Gjirokaster doctor Hysni Lluka told local Top Channel TV.  Lluka said women and teenagers, who account for some 40% of those working in the notorious cannabis district of Lazarat, had sought help for vomiting, stomach pain, irregular heart beats and high blood pressure. One patient reportedly arrived "in a critical state." Uninitiated readers are left with the clear impression that harvesters were suffering from severe cannabis intoxication.

A new riot between rival gangs in the dangerously overcrowded prison at  Altamira, in the Mexican border state Tamaulipas, left seven inmates dead Oct. 26.  State authorities said the prisoners were killed with makeshift knives in a fight in one cellblock at the facility, officially known as the Execution and Sanction Center (CEDES). Thirty-one inmates died in a riot in the same prison early last year, pointing to a crisis rooted in the confluence of teeming lock-ups and the bloody narco wars being waged in Tamaulipas both inside and outside the prisons. The state is currently Mexico's most violent. The CEDES was designed to hold 2,000 inmates, but now has a population of more than 3,000. (AP, Notimex, Oct. 26)

Jamaica's Justice Minister Mark Golding says his office is preparing an initiative to legalize cannabis in the island nation—pointing to the successful state initiatives in the US, traditionally the chief opponent of such efforts by Caribbean countries. "The Ministry of Justice is far advanced in developing a Cabinet submission with a view to reforming the laws relating to ganja," Golding told Jamaica's The Gleaner Oct. 7. "We have been working on that for some time now, and it's at an advanced stage, so Cabinet will get the opportunity to consider our recommendation and we will see whether the Cabinet is minded to move forward in the way that we have proposed."

Israel has the world's highest proportion of registered medical marijuana users—but the program has been kept under tight control of the Health Ministry. Now, Israel's parliament, the Knesset, is set to vote on a bill that would allow private physicians to prescribe cannabis for their patients. Health Minister Yael German opposes the measure, making the usual argument that it would open the floodgates of recreational use: "It would not be unrealistic to assume that there would be patients who would pressure doctors to write them a cannabis prescription for any bump, headache or toothache."

Italian police say Albania, the impoverished Balkan country just across the Adriatic Sea, is the source for vast quantities of cannabis entering G8 and EU member Italy. In the latest major haul in July, Italian Finance Police intercepted a full metric ton of cannabis from a speedboat along the coast of southern Puglia region. Four crewmen were arrested—two Italian and two Albanian. This came one month after the Finance Police released the results of months of air reconnaissance of Albania's hinterland, undertaken in a joint operation with Albanian police—identifying 500 cannabis plantations, accounting for a combined production of 1,000 metric tons with an estimated retail value of 4.5 billion euros. Over the past 20 years since the fall of its rigidly closed Communist dictatorship, Albania has won the title of "Europe's Afghanistan" for its prodigious cannabis production.

Algeria  seized more than 127 metric tons of hashish coming in from Morocco in the first eight months of 2013, authorities announced Oct. 2. Some 12,500 suspected traffickers were arrested and large quantities of various  psychotropic pills were also confiscated in raids. (These two trades seem to together in Middle East networks.) Algeria has officially closed its border with the conservative kingdom to the west since 1994, citing political tensions and the flow of contraband. But the trade obviously flourishes, with subsidized Algerian fuel  smuggled into Morocco in a dope-for-oil deal. In 2012, more than 157 tons of cannabis were seized in Algeria, compared with 53  in 2011. The explosion has prompted Algiers to beef up security on its western frontier. (Lebanon Daily Star, Oct. 2)

The US Supreme Court on Oct. 7 rejected a challenge to the federal government's classification of cannabis as a Schedule I drug with no legitimate medical use. Challenger Americans for Safe Access contended that more than 200 studies have established that cannabis is safe and effective in relieving pain and nausea, and in relieving the effects of chemotherapy, among other medical uses. But federal courts have let stand the Drug Enforcement Administration's stance that the studies are insufficient.